1 . Khoury DS, Cromer D, Reynaldi A, Schlub TE, Wheatley AK, Juno JA, et al.. "Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection" . Nat Med. 2021May; 27:1205–11.

2 . Logunov DY, Dolzhikova IV, Shcheblyakov DV, Tukhvatulin AL, Zubkova OV, Dzharullaeva AS, et al.. "Gam-COVID-Vac Vaccine Trial Group Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia" . Lancet. 2021Feb2; 397(10275):671–81.

3 . Parry HM, Bruton R, Tut G, Ali M, Stephens C, Faustini S, et al.. "Single Vaccination with BNT162b2 or ChAdOx1 in Older People Induces Equivalent Antibody Generation but Enhanced Cellular Responses after ChAdOx1" . SSRN [Preprint]. 2021 [cited 2021 November 20]. Available from: DOI: 10.2139/ssrn.3825573

4 . Bernal JL, Andrews N, Gower C, Stowe J, Robertson C, Tessier E, et al.. "Early effectiveness of COVID-19 vaccination with BNT162b2 mRNA vaccine and ChAdOx1 adenovirus vector vaccine on symptomatic disease, hospitalisations and mortality in older adults in England" . medRxiv 21252652 [Preprint]. 2021 [cited 2021 November 20]. Available from: DOI: 10.1101/2021.03.01.21252652

5 . Polack FP, Thomas SJ, Kitchin N, Absalon J, Gurtman A, Lockhart S, et al.. "Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine" . N Engl J Med. 2020Dec10; 383:2603–15.

6 . Lumley SF, O’Donnell D, Stoesser NE, Matthews PC, Howarth A, Hatch SB, et al.. Oxford University Hospitals Staff Testing Group. "Antibody status and incidence of SARS-CoV-2 infection in health care workers" . N Engl J Med. 2021Feb;11; 384:533–40.

7 . Angyal A, Longet S, Moore S, Payne RP, Harding A, Tipton T, et al.. "T-cell and antibody responses to first BNT162b2 vaccine dose in previously SARS-CoV-2-infected and infection-naive UK healthcare workers: a multicentre, prospective, observational cohort study" . Lancet Microbe. 2022Jan; 3(1):e21–e31.

8 . Müller L, Andrée M, Moskorz W, Drexler I, Walotka L, Grothmann R, et al.. "Age-dependent immune response to the Biontech. Pfizer BNT162b2 COVID-19 vaccination" . Clin Infect Dis. 2021Dec1; 73(11):2065–72.

9 . Chang WH. "A review of vaccine effects on women in light of the COVID-19 pandemic" . Taiwan J Obstet Gynecol. 2020Sep11; 59(6):812–20

10 . Wei J, Stoesser N, Matthews PC, Ayoubkhani D, Studley R, Bell I, et al.. "Antibody responses to SARS-CoV-2 vaccines in 45,965 adults from the general population of the United Kingdom" . Nat Microbiol. 2021Sep; 6(9):1140–9.

11 . Klein SL, Flanagan KL, Plebanski M, Klein SL. "Sex differences in immune responses" . Nat Rev Immunol. 2016Oct; 16(10):626–38.

12 . Choudhary HR, Parai D, Dash GC, Peter A, Sahoo SK, Pattnaik M, et al.. "IgG antibody response against Nucleocapsid and Spike protein post SARS-CoV-2 infection" . Res Sq [Preprint]. 2021 [cited 2021 November 20]. Available from: DOI: 10.21203/rs.3.rs-490375/v1

13 . Levin EG, Lustig Y, Cohen C, Fluss R, Indenbaum V, Amit S, et al.. "Waning immune humoral response to BNT162b2 Covid-19 vaccine over 6 months" . N Engl J Med. 2021Oct6; 385(24), e84.